NCT05251727 2024-08-19Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer PatientsVeloxis PharmaceuticalsPhase 1 Terminated77 enrolled
NCT02792842 2024-04-04Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon CancerAsahi Kasei Pharma CorporationPhase 2 Completed79 enrolled 10 charts